This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): SSR-180711
Description: SSR180711 is a selective alpha7 acetylcholine nicotinic receptor (n-AChRs) partial agonist. SSRI180711 has shown activity in several preclinical models of cognitive deficits in schizophrenia.
Additional information available to subscribers only: